Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Cody A. Ramirez(James S. McDonnell Foundation), Todd A. Fehniger(Washington University in St. Louis), Sweta Desai(Washington University in St. Louis), Marcus P. Watkins(Washington University in St. Louis), Susanna Kiwala(Washington University in St. Louis), Erica K. Barnell(Washington University in St. Louis), Elena Ocheredko(Addgene), Amanda F. Cashen(Washington University in St. Louis), Vladislav Belousov(Addgene), Malachi Griffith(Washington University in St. Louis), David A. Russler‐Germain(Washington University in St. Louis), Alexander Bagaev(Lomonosov Moscow State University), Michelle Becker‐Hapak(Washington University in St. Louis), Zachary L. Skidmore(James S. McDonnell Foundation), Catrina C. Fronick(Washington University in St. Louis), Jasreet Hundal(James S. McDonnell Foundation), Felicia Gomez(James S. McDonnell Foundation), Jason Walker(James S. McDonnell Foundation), Robert S. Fulton(St. Jude Children's Research Hospital), Timothy Schappe(Washington University in St. Louis), Neha Mehta–Shah(The University of Texas MD Anderson Cancer Center), Kilannin Krysiak(James S. McDonnell Foundation), Brad S. Kahl(UW Health University Hospital), Nancy L. Bartlett(Washington University in St. Louis), Ethan McClain(Washington University in St. Louis), Felix Frenkel(Addgene), Thomas B. Mooney(James S. McDonnell Foundation), Robert D. Schreiber(Washington University in St. Louis), Ravshan Ataullakhanov(Addgene), Olga Kudryashova(Addgene), Onyinyechi C. Onyeador(Washington University in St. Louis), Kartik Singhal(Washington University in St. Louis), Obi L. Griffith(Washington University in St. Louis)
Blood Advances
May 7, 2024
Cited by 12


Related Papers